Skip to main content
Top
Published in: Pediatric Nephrology 7/2016

01-07-2016 | Clinical Quiz

An infant with nephrolithiasis and renal failure: Answers

Authors: Kazuyuki Ueno, Masaki Shimizu, Tatsuya Kubo, Noboru Igarashi, Kiyoshi Hatasaki

Published in: Pediatric Nephrology | Issue 7/2016

Login to get access

Excerpt

1.
2,8-Dihydroxyadenine (DHA) crystals
 
2.
Adenine phosphoribosyltransferase (ARPT) deficiency
Blood examination revealed anemia, severe impaired renal function, hyperuricemia, and hyperphosphatemia. The urinary sediment showed multiple spherical and reddish-brown particles with a dark outline and central spicules which are characteristic to 2,8-DHA crystals. Computed tomography showed multiple renal stones. Based on these findings, we diagnosed the patient with chronic kidney disease associated with APRT deficiency.
The diagnosis of APRT deficiency disease in our patient was made and confirmed by: (1) characterization of 2,8-DHA crystals in the urinary sediment; (2) sensitivity of proliferating T lymphocytes in response to an adenine analog, the cytotoxicity of which is dependent on APRT (T-cell method); (3) molecular analysis of the APRT gene.
Microscopic examination of the urinary sediment revealed multiple spherical and reddish-brown particles with a dark outline and central spicules that looked like “Maltese crosses” under polarized light. A semi-qualitative spectrophotometric analysis of the removed renal stones revealed a curve very similar to that of 2,8-DHA. The T-cell method showed that the patient was homozygous or compound heterozygous for an APRT gene mutation. Genetic analysis of the APRT gene confirmed the diagnosis of APRT deficiency and revealed a compound heterozygous state for p.M136T (APRT*J) and p.W98X (APRT*Q0).
In addition to APRT deficiency, the patient had left vesicoureteral reflux (grade III) and a right ureterocele, which was confirmed by voiding cystourethrogram. Medical therapy was started with allopurinol (10 mg/kg). The patient is now 24 months old and creatinine remains elevated (1.3 mg/dl).
 
Literature
1.
go back to reference Bouzidi H, Lacour B, Daudon M (2007) 2,8-Dihydroxyadenine nephrolithiasis: from diagnosis to therapy. Ann Biol Clin (Paris) 65:585–592 Bouzidi H, Lacour B, Daudon M (2007) 2,8-Dihydroxyadenine nephrolithiasis: from diagnosis to therapy. Ann Biol Clin (Paris) 65:585–592
2.
go back to reference Edvardsson V, Palsson R, Olafsson I, Hjaltadottir G, Laxdal T (2001) Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am J Kidney Dis 38:473–480CrossRefPubMed Edvardsson V, Palsson R, Olafsson I, Hjaltadottir G, Laxdal T (2001) Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am J Kidney Dis 38:473–480CrossRefPubMed
3.
go back to reference Kelley WN, Levy RI, Rosenbloom FM, Henderson JF, Seegmiller JE (1968) Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest 47:2281–2289CrossRefPubMedPubMedCentral Kelley WN, Levy RI, Rosenbloom FM, Henderson JF, Seegmiller JE (1968) Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest 47:2281–2289CrossRefPubMedPubMedCentral
4.
go back to reference Wyngaarden JB, Dunn JT (1957) 8-Hydroxyadenine as the intermediate in the oxidation of adenine to 2, 8-dihydroxyadenine by xanthine oxidase. Arch Biochem Biophys 70:150–156CrossRefPubMed Wyngaarden JB, Dunn JT (1957) 8-Hydroxyadenine as the intermediate in the oxidation of adenine to 2, 8-dihydroxyadenine by xanthine oxidase. Arch Biochem Biophys 70:150–156CrossRefPubMed
5.
go back to reference Bollée G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, Deteix P, Daudon M, Knebelmann B, Ceballos-Picot I (2010) Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 21:679–688CrossRefPubMedPubMedCentral Bollée G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, Deteix P, Daudon M, Knebelmann B, Ceballos-Picot I (2010) Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 21:679–688CrossRefPubMedPubMedCentral
6.
go back to reference Stratta P, Fogazzi GB, Canavese C, Airoldi A, Fenoglio R, Bozzola C, Ceballos-Picot I, Bollée G, Daudon M (2010) Decreased kidney function and crystal deposition in the tubules after kidney transplant. Am J Kidney Dis 56:585–590CrossRefPubMed Stratta P, Fogazzi GB, Canavese C, Airoldi A, Fenoglio R, Bozzola C, Ceballos-Picot I, Bollée G, Daudon M (2010) Decreased kidney function and crystal deposition in the tubules after kidney transplant. Am J Kidney Dis 56:585–590CrossRefPubMed
7.
go back to reference Van Acker KJ, Simmonds HA, Potter C, Cameron JS (1977) Complete deficiency of adenine phosphoribosyltransferase. Report of a family. N Engl J Med 297:127–132CrossRefPubMed Van Acker KJ, Simmonds HA, Potter C, Cameron JS (1977) Complete deficiency of adenine phosphoribosyltransferase. Report of a family. N Engl J Med 297:127–132CrossRefPubMed
8.
go back to reference Suzuki K, Kobayashi S, Kawamura K, Kuhara T, Tsugawa R (1997) Family study of 2,8-dihydroxyadenine stone formation: report of two cases of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0). Int J Urol 4:304–306CrossRefPubMed Suzuki K, Kobayashi S, Kawamura K, Kuhara T, Tsugawa R (1997) Family study of 2,8-dihydroxyadenine stone formation: report of two cases of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0). Int J Urol 4:304–306CrossRefPubMed
Metadata
Title
An infant with nephrolithiasis and renal failure: Answers
Authors
Kazuyuki Ueno
Masaki Shimizu
Tatsuya Kubo
Noboru Igarashi
Kiyoshi Hatasaki
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2016
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-015-3100-z

Other articles of this Issue 7/2016

Pediatric Nephrology 7/2016 Go to the issue

Letter to the Editors

Adverse effects of nephrectomy